The Z Stitch Early Bed Rest Assessment Study
Launched by OREGON HEALTH AND SCIENCE UNIVERSITY · Oct 12, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The Z Stitch Early Bed Rest Assessment Study is looking at how soon patients can get up and move around after a heart procedure that involves a Z stitch. The goal is to see if getting up earlier, instead of staying in bed for a longer time, makes patients feel happier about their care and possibly helps them leave the hospital sooner. Patients aged 18 to 99 who are having treatments for heart conditions like atrial fibrillation or supraventricular tachycardia may be eligible to participate.
In this study, participants will be divided into two groups: one group will rest for one hour after the procedure, while the other will rest for four hours. Researchers will then compare the experiences of both groups to see if those who had less bed rest reported greater satisfaction. It’s important to note that some individuals, like those who cannot give consent or have certain health conditions, may not qualify for this trial. If you’re considering joining, you can expect to share your feelings about your recovery and help researchers learn more about how to improve patient care after heart procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Presenting for procedure in the EP lab for:
- • Atrial fibrillation
- • Atrial flutter
- • Supraventricular tachycardia
- • Diagnostic EP study
- • Atrioventricular node ablation
- • Watchman device placement
- Exclusion Criteria:
- • Those who refuse or are unable to consent.
- • Cases involving arterial access.
- • Cases involving access with a \>16Fr sheath (i.e., no leadless pacer patients).
- • Patients with a BMI \> 40.
- • Lead-extraction patients.
About Oregon Health And Science University
Oregon Health and Science University (OHSU) is a leading academic medical center dedicated to advancing health through research, education, and patient care. As a prominent sponsor of clinical trials, OHSU leverages its extensive expertise in various medical fields to facilitate innovative research aimed at improving patient outcomes. The institution is committed to ethical standards and rigorous scientific methodologies, fostering collaborations that enhance the development of new therapies and interventions. With a focus on translating research discoveries into clinical practice, OHSU plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portland, Oregon, United States
Portland, Oregon, United States
Patients applied
Trial Officials
Charles Henrikson, MD
Principal Investigator
Oregon Health and Science University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported